Related references
Note: Only part of the references are listed.Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
β-Arrestin2 Contributes to Cell Viability and Proliferation via the Down-Regulation of FOXO1 in Castration-Resistant Prostate Cancer
Xiaolu Duan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
Over-Expression of Lipocalin 2 Promotes Cell Migration and Invasion Through Activating ERK Signaling to Increase SLUG Expression in Prostate Cancer
Guanxiong Ding et al.
PROSTATE (2015)
Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis
Fei Gao et al.
ONCOTARGET (2015)
Androgen Receptor Splice Variants Contribute to Prostate Cancer Aggressiveness Through Induction of EMT and Expression of Stem Cell Marker Genes
Dejuan Kong et al.
PROSTATE (2015)
MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A
T. Sun et al.
ONCOGENE (2014)
ERG-SOX4 interaction promotes epithelial-mesenchymal transition in prostate cancer cells
Lin Wang et al.
PROSTATE (2014)
Delivering RNAi therapeutics with non-viral technology: a promising strategy for prostate cancer?
Jianfeng Guo et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells
Zhigang Zhao et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Prostate Stem Cell Antigen, a Presumable Organ-Dependent Tumor Suppressor Gene, is Down-Regulated in Gallbladder Carcinogenesis
Hiroe Ono et al.
GENES CHROMOSOMES & CANCER (2012)
Peripheral blood reverse transcription PCR assay for prostate stem cell antigen correlates with androgen-independent progression in advanced prostate cancer
Zhigang Zhao et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
GLIPR1 Tumor Suppressor Gene Expressed by Adenoviral Vector as Neoadjuvant Intraprostatic Injection for Localized Intermediate or High-Risk Prostate Cancer Preceding Radical Prostatectomy
Guru Sonpavde et al.
CLINICAL CANCER RESEARCH (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways
Emanuele Marra et al.
BMC CANCER (2010)
Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?
Norihisa Saeki et al.
CLINICAL CANCER RESEARCH (2010)
ZEB1 Coordinately Regulates Laminin-332 and β4 Integrin Expression Altering the Invasive Phenotype of Prostate Cancer Cells
Justin M. Drake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Prostate cancer as a model for tumour immunotherapy
Charles G. Drake
NATURE REVIEWS IMMUNOLOGY (2010)
ZEB1 Enhances Transendothelial Migration and Represses the Epithelial Phenotype of Prostate Cancer Cells
Justin M. Drake et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1954
Prashant Patel et al.
MOLECULAR THERAPY (2009)
Epithelial-mesenchymal and mesenchymal - Epithelial transitions in carcinoma progression
Honor Hugo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Cancer metastasis:: Building a framework
Gaorav P. Gupta et al.
CELL (2006)
Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: Implications for prostate carcinogenesis and progression of prostate cancer (vol 34, pg 414, 2004)
ZG Zhao et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2006)
Prostate stem cell antigen is overexpressed in prostate cancer metastases
JS Lam et al.
CLINICAL CANCER RESEARCH (2005)
Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer
KR Han et al.
JOURNAL OF UROLOGY (2004)
PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112
G Bahrenberg et al.
CANCER LETTERS (2001)
Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer
Z Gu et al.
ONCOGENE (2000)